Are lipid abnormalities reliable cardiovascular risk factors in dialysis patients?
Patients on chronic hemodialysis often present both hyperlipidemia and a high incidence of cardiovascular disease (CVD). Uremic hyperlipidemia has usually been regarded as one of the most important cardiovascular risk factors (CVRF) in these patients. In order to study whether the "uremia-induced" lipid abnormalities are actually associated with evidence of uremic CVD, and consequently may be considered reliable CVRF, 123 patients on chronic dialysis were reviewed for the presence of CVD and, at the same time, examined for their lipoprotein pattern and other clinical and biochemical variables. Lipids and lipoproteins did not prove helpful in our study in identifying patients with CVD. Despite the fact that they had been on dialysis for a shorter time, CVD patients were significantly older and had higher blood pressure than patients without CVD. Our data suggest that the uremia-induced lipid abnormalities are not reliable markers of CVD in dialysis patients, and support the hypothesis that dialysis per se does not accelerate the atherosclerotic process in uremic patients.
Bergesio
F
F
Department of Nephrology and Dialysis, New Hospital of S. Giovanni di Dio, Florence, Italy.
Ciuti
R
R
Salvadori
M
M
Galli
G A
GA
Monzani
G
G
Bertoni
E
E
Salerno
A
A
Frizzi
V
V
D000368:Aged; D002318:Cardiovascular Diseases / Q000097:blood / Q000150:complications / Q000209:etiology*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014511:Uremia / Q000150:complications / Q000628:therapy
D008055:Lipids; D008074:Lipoproteins